20 June 2013
Keywords: imclone, starts, ph, ii, enrollment, imc-a12, drug
Article | 23 July 2007
US drug developer ImClone Systems says that the first of its Phase II clinical trials with the anti-insulin-like growth factor-1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2007
19 June 2013
© 2013 thepharmaletter.com